These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21843941)

  • 1. Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonists.
    Zhou D; Gross JL; Sze JY; Adedoyin AB; Bowlby M; Di L; Platt BJ; Zhang G; Brandon N; Comery TA; Robichaud AJ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5957-60. PubMed ID: 21843941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.
    Zhou D; Gross JL; Adedoyin AB; Aschmies SB; Brennan J; Bowlby M; Di L; Kubek K; Platt BJ; Wang Z; Zhang G; Brandon N; Comery TA; Robichaud AJ
    J Med Chem; 2012 Mar; 55(5):2452-68. PubMed ID: 22313242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonists.
    Stocking EM; Aluisio L; Atack JR; Bonaventure P; Carruthers NI; Dugovic C; Everson A; Fraser I; Jiang X; Leung P; Lord B; Ly KS; Morton KL; Nepomuceno D; Shah CR; Shelton J; Soyode-Johnson A; Letavic MA
    Bioorg Med Chem Lett; 2010 May; 20(9):2755-60. PubMed ID: 20382018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain.
    Altenbach RJ; Black LA; Strakhova MI; Manelli AM; Carr TL; Marsh KC; Wetter JM; Wensink EJ; Hsieh GC; Honore P; Garrison TR; Brioni JD; Cowart MD
    J Med Chem; 2010 Nov; 53(21):7869-73. PubMed ID: 20945906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonists.
    Cole DC; Gross JL; Comery TA; Aschmies S; Hirst WD; Kelley C; Kim JI; Kubek K; Ning X; Platt BJ; Robichaud AJ; Solvibile WR; Stock JR; Tawa G; Williams MJ; Ellingboe JW
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1237-40. PubMed ID: 20042333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of pyridone-phenoxypropyl-R-2-methylpyrrolidine analogues as histamine H3 receptor antagonists.
    Becknell NC; Lyons JA; Aimone LD; Gruner JA; Mathiasen JR; Raddatz R; Hudkins RL
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7076-80. PubMed ID: 22014551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.
    Brown DG; Bernstein PR; Griffin A; Wesolowski S; Labrecque D; Tremblay MC; Sylvester M; Mauger R; Edwards PD; Throner SR; Folmer JJ; Cacciola J; Scott C; Lazor LA; Pourashraf M; Santhakumar V; Potts WM; Sydserff S; Giguère P; Lévesque C; Dasser M; Groblewski T
    J Med Chem; 2014 Feb; 57(3):733-58. PubMed ID: 24410637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new family of H3 receptor antagonists based on the natural product Conessine.
    Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Sengupta D; Duffield JJ; Semple G; Webb RR; Sage C; Ren A; Pereira G; Knudsen J; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Whelan K; Grottick AJ
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1490-4. PubMed ID: 18194865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amine-constrained pyridazinone histamine H₃ receptor antagonists.
    Sundar BG; Bailey T; Bacon E; Aimone L; Huang Z; Lyons J; Raddatz R; Hudkins R
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5543-6. PubMed ID: 21824776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, and biological assessment of the four stereoisomers of the H(3) receptor antagonist 5-fluoro-2-methyl-N-[2-methyl-4-(2-methyl[1,3']bipyrrolidinyl-1'-yl)phenyl]benzamide.
    Gao Z; Hurst WJ; Guillot E; Nagorny R; Pruniaux MP; Hendrix JA; George PG
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4044-7. PubMed ID: 23769643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.
    Fish PV; Wakenhut F; Ryckmans T; Stobie A
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4579-83. PubMed ID: 19616432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel imidazole-based histamine H3 antagonists.
    Jablonowski JA; Ly KS; Bogenstaetter M; Dvorak CA; Boggs JD; Dvorak LK; Lord B; Miller KL; Mazur C; Wilson SJ; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2009 Feb; 19(3):903-7. PubMed ID: 19119007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of aminobenzyloxyarylamides as κ opioid receptor selective antagonists: application to preclinical development of a κ opioid receptor antagonist receptor occupancy tracer.
    Mitch CH; Quimby SJ; Diaz N; Pedregal C; de la Torre MG; Jimenez A; Shi Q; Canada EJ; Kahl SD; Statnick MA; McKinzie DL; Benesh DR; Rash KS; Barth VN
    J Med Chem; 2011 Dec; 54(23):8000-12. PubMed ID: 21958337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series.
    Nersesian DL; Black LA; Miller TR; Vortherms TA; Esbenshade TA; Hancock AA; Cowart MD
    Bioorg Med Chem Lett; 2008 Jan; 18(1):355-9. PubMed ID: 18077160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists.
    Zeng Q; Rosenblum SB; Yang Z; Jiang Y; McCormick KD; Aslanian RG; Duguma L; Kozlowski JA; Shih NY; Hey JA; West RE; Korfmacher WA; Berlin M; Boyce CW
    Bioorg Med Chem Lett; 2013 Nov; 23(21):6001-3. PubMed ID: 24050887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).
    Stalder H; Hoener MC; Norcross RD
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1227-31. PubMed ID: 21237643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H₃ receptor antagonists with potent cognition enhancing activity.
    Tao M; Aimone LD; Huang Z; Mathiasen J; Raddatz R; Lyons J; Hudkins RL
    J Med Chem; 2012 Jan; 55(1):414-23. PubMed ID: 22107017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of the benzazepine class of histamine H3 receptor antagonists.
    Wilson DM; Apps J; Bailey N; Bamford MJ; Beresford IJ; Briggs MA; Calver AR; Crook B; Davis RP; Davis S; Dean DK; Harris L; Heightman TD; Panchal T; Parr CA; Quashie N; Steadman JG; Schogger J; Sehmi SS; Stean TO; Takle AK; Trail BK; White T; Witherington J; Worby A; Medhurst AD
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6897-901. PubMed ID: 24161834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and preliminary pharmacological investigation of new N-substituted-N-[ω-(ω-phenoxy-alkylpiperazin-1-yl)alkyl]guanidines as non-imidazole histamine H(3) antagonists.
    Staszewski M; Walczyński K
    Arch Pharm (Weinheim); 2012 Jun; 345(6):431-43. PubMed ID: 22415744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists.
    Nirogi R; Shinde A; Tiriveedhi V; Kota L; Saraf SK; Badange RK; Mohammed AR; Subramanian R; Muddana N; Bhyrapuneni G; Abraham R
    Eur J Med Chem; 2016 Jan; 108():655-662. PubMed ID: 26731168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.